Log in

3001 Katakura Industries Co., Ltd. TSE · Japan

Katakura Industries Co. (3001) news

Katakura Industries Co., Ltd. is a public biotech or pharmaceutical company listed on TSE under the ticker 3001, recorded under Japan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Katakura Industries Co. news

We have not published a story on Katakura Industries Co. yet. When there is news, it will appear here.

Questions about Katakura Industries Co.

What is the ticker symbol of Katakura Industries Co.?

Katakura Industries Co., Ltd. trades under the ticker 3001 on TSE.

Where is Katakura Industries Co. listed?

Katakura Industries Co., Ltd. is listed on TSE.

Which country or territory is Katakura Industries Co. listed under?

Our directory records Katakura Industries Co., Ltd. under Japan.

What does Katakura Industries Co. do?

Our directory classifies Katakura Industries Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Katakura Industries Co.?

The ISIN recorded for Katakura Industries Co., Ltd. is JP3211400001.

Does aibio.space cover Katakura Industries Co.?

aibio.space lists Katakura Industries Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Katakura Industries Co.?

Companies in our directory listed in the same country and business area as Katakura Industries Co.: Taiko Pharmaceutical Co., D.Western Therapeutics Institute, Sumitomo Pharma Co.Ltd., Earth, Fuji Pharma Co., Kaken Pharmaceutical Co..

Investor discussion: Katakura Industries Co.

Members talk about Katakura Industries Co. (3001). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSE:3001 on TradingView.

Listing details

Katakura Industries Co., Ltd. is a public biotech or pharmaceutical company listed on TSE under the ticker 3001, recorded under Japan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Katakura Industries Co., Ltd.
Ticker
3001
Listing
TSE
Country or territory
Japan
Business scope
Pharmaceuticals: Major
ISIN
JP3211400001
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.